Does CARMUSTINE Cause Myelodysplastic syndrome? 295 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 295 reports of Myelodysplastic syndrome have been filed in association with CARMUSTINE (carmustine). This represents 8.7% of all adverse event reports for CARMUSTINE.
295
Reports of Myelodysplastic syndrome with CARMUSTINE
8.7%
of all CARMUSTINE reports
153
Deaths
41
Hospitalizations
How Dangerous Is Myelodysplastic syndrome From CARMUSTINE?
Of the 295 reports, 153 (51.9%) resulted in death, 41 (13.9%) required hospitalization, and 29 (9.8%) were considered life-threatening.
Is Myelodysplastic syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARMUSTINE. However, 295 reports have been filed with the FAERS database.
What Other Side Effects Does CARMUSTINE Cause?
Off label use (454)
Febrile neutropenia (297)
Disease progression (241)
Acute myeloid leukaemia (180)
Thrombocytopenia (174)
Pyrexia (152)
Drug ineffective (149)
Mucosal inflammation (148)
Second primary malignancy (141)
Infection (139)
What Other Drugs Cause Myelodysplastic syndrome?
CYCLOPHOSPHAMIDE (1,545)
LENALIDOMIDE (1,285)
DOXORUBICIN (1,236)
RITUXIMAB (1,054)
VINCRISTINE (966)
ETOPOSIDE (936)
DEXAMETHASONE (759)
METHOTREXATE (728)
CYTARABINE (715)
CARBOPLATIN (698)
Which CARMUSTINE Alternatives Have Lower Myelodysplastic syndrome Risk?
CARMUSTINE vs CARTEOLOL
CARMUSTINE vs CARVEDILOL
CARMUSTINE vs CASIMERSEN
CARMUSTINE vs CASIRIVIMAB
CARMUSTINE vs CASIRIVIMAB\IMDEVIMAB